US Patent Issued to HALOZYME on July 14 for "Combination therapy with antibody-drug conjugates and hyaluronidases" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,492, issued on July 14, was assigned to HALOZYME INC. (San Diego). "Combination therapy with antibody-drug conjugates and hyaluronidases" w... Read More

US Patent Issued to Yale University on July 14 for "Compositions and methods for multiplexed tumor vaccination with endogenous gene activation" (Connecticut, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,493, issued on July 14, was assigned to Yale University (New Haven, Conn.). "Compositions and methods for multiplexed tumor vaccination wit... Read More

US Patent Issued to CELLTRION on July 14 for "Immunogenic composition comprising multivalent Streptococcus pneumoniae polysaccharide-protein conjugates" (South Korean Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,494, issued on July 14, was assigned to CELLTRION INC. (Incheon, South Korea). "Immunogenic composition comprising multivalent Streptococcu... Read More

US Patent Issued to STATENS SERUM INSTITUT on July 14 for "Vaccines against chlamydia sp" (Danish Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,495, issued on July 14, was assigned to STATENS SERUM INSTITUT (Copenhagen S, Denmark). "Vaccines against chlamydia sp" was invented by Fra... Read More

US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on July 14 for "Gold nanoparticle intranasal vaccine compositions" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,496, issued on July 14, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.). "Gold nanopartic... Read More

US Patent Issued to BioNTech, TRON - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gemeinnutzige on July 14 for "Compositions comprising non-immunogenic RNA encoding immunogenic epitopes and interferon alpha" (German Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,497, issued on July 14, was assigned to BioNTech SE (Mainz, Germany) and TRON - Translationale Onkologie an der Universitatsmedizin der Joha... Read More

US Patent Issued to ASTEX THERAPEUTICS on July 14 for "FGFR/PD-1 combination therapy for the treatment of cancer" (Maryland, Pennsylvania Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,498, issued on July 14, was assigned to ASTEX THERAPEUTICS LTD (Cambridge, Great Britain). "FGFR/PD-1 combination therapy for the treatment... Read More

US Patent Issued to Iovance Biotherapeutics on July 14 for "Treatment with tumor infiltrating lymphocyte therapies in combination with CTLA-4 and PD-1 inhibitors" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,499, issued on July 14, was assigned to Iovance Biotherapeutics Inc. (San Carlos, Calif.). "Treatment with tumor infiltrating lymphocyte th... Read More

US Patent Issued on July 14 for "Pathogen destruction system and method using magnetic markers" (Colorado Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,500, issued on July 14. "Pathogen destruction system and method using magnetic markers" was invented by Abron Arrington (Denver). Accordin... Read More

US Patent Issued to MEMORIAL SLOAN-KETTERING CANCER CENTER on July 14 for "Modulating permeability of the blood cerebrospinal fluid barrier" (New York Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,501, issued on July 14, was assigned to MEMORIAL SLOAN-KETTERING CANCER CENTER (New York). "Modulating permeability of the blood cerebrospi... Read More

• ««
• «
• 174465
• 174466
• 174467
• 174468
• 174469
• 174470
• 174471
• 174472
• 174473
• 174474
• »
• »»